Recerca

Tractament del càncer pediàtric

Buscador de publicacions

Publicacions

  • Figueras-Nart I, Vicente-Villa MA, Sánchez-Schmidt J, Jou-Munoz C, Bordas-Orpinell X, Celis-Passini VP, Cruz-Martínez O and González-Enseñat MA.

    Langerhans cell histiocytosis presenting as fingernail changes.

    JAAD case reports . 2(6): 485-487.

    [doi:10.1016/j.jdcr.2016.05.005]

  • Moreno L, García Ariza MA, Cruz-Martínez O, Calvo C, Fuster JL, Salinas JA, Moscardo C, Portugal R, Merino JM and Madero L.

    Liposomal cytarabine for the treatment of leptomeningeal dissemination of central nervous system tumours in children and adolescents

    ANALES DE PEDIATRIA . 85(5): 2741-2748.

    [doi:10.1016/j.anpedi.2016.02.007]

  • Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.

    Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination

    CANCER LETTERS . 380(1): 10-19. Nº de cites: 25

    [doi:10.1016/j.canlet.2016.06.012]

  • Jansen MH, Lagerweij T, Sewing AC, Vugts DJ, van Vuurden DG, Molthoff CF, Caretti V, Veringa SJ, Petersen N, Carcaboso AM, Noske DP, Vandertop WP, Wesseling P, van Dongen GA, Kaspers GJ and Hulleman E.

    Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models

    MOLECULAR CANCER THERAPEUTICS . 15(9): 2166-2174. Nº de cites: 50

    [doi:10.1158/1535-7163.MCT-15-0558]

  • Zacharoulis S, Morales-La Madrid A, Bandopadhayay P, Chi SN, Manley P, Ullrich NN, Marcus K, Goumnerova L, Scott RM, Proctor M, Young-Poussaint T, De Girolami U and Kieran MW.

    Central Versus Extraventricular Neurocytoma in Children: A Clinicopathologic Comparison and Review of the Literature

    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY . 38(6): 479-485. Nº de cites: 10

    [doi:10.1097/MPH.0000000000000627]

  • Winter U, Mena HA, Negrotto S, Arana E, Pascual-Pastó G, Laurent V, Suñol M, Chantada G, Carcaboso AM and Schaiquevich P.

    Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells

    PLoS One . 11(7): . Nº de cites: 21

    [doi:10.1371/journal.pone.0160094]

  • Hernandez-Muñoz I, Figuerola-Bou E, Sánchez-Molina S, Rodriguez E, Fernández-Mariño AI, Pardo-Pastor C, Bahamonde MI, Fernández-Fernández JM, García-Domínguez DJ, Hontecillas-Prieto L, Lavarino C, Carcaboso AM, de Torres C, Tirado OM, de Alava E and Mora J.

    RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-?B pathway, independently of the fusion oncoprotein

    Oncotarget . 7(29): 46283-46300. Nº de cites: 12

    [doi:10.18632/oncotarget.10092]

  • Veldhuijzen van Zanten, S.E.M., Cruz-Martínez O, Kaspers, G.J.L., Hargrave, D.R., van Vuurden, D.G. and Siope Dipg Network.

    State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature.

    JOURNAL OF NEURO-ONCOLOGY . 128(3): 387-394. Nº de cites: 20

    [doi:10.1007/s11060-016-2141-x]

  • Bautista F, Gallego S, Cañete A, Mora J, Diaz de Heredia C, Cruz-Martínez O, Fernández JM, Rives-Solà S, Madero L, Castel V, Cela ME, Ramírez G, Sábado C, Acha T, Astigarraga I, Sastre A, Muñoz A, Guibelalde M and Moreno L.

    Landscape of early clinical trials for childhood and adolescence cancer in Spain

    CLINICAL & TRANSLATIONAL ONCOLOGY . 18(7): 708-713. Nº de cites: 6

    [doi:10.1007/s12094-015-1421-9]

  • Millan NC, Poveda MJ, Cruz-Martínez O and Mora J.

    Safety of bevacizumab in patients younger than 4 years of age

    CLINICAL & TRANSLATIONAL ONCOLOGY . 18(5): 464-468. Nº de cites: 11

    [doi:10.1007/s12094-015-1389-5]